id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-018884-os0faovj	Peghin, Maddalena	Prevention and Treatment of Respiratory Virus Infection	2019-03-01		.txt	text/plain	5431	274	36	There is increasing recognition of infections caused by respiratory viruses (RVs) as a major cause of morbidity and mortality in solid organ transplant (SOT) recipients, especially within the thoracic and pediatric population. Respiratory viral infections are typically caused by rhinovirus (RhVs), coronavirus (CoV), respiratory syncytial virus (RSV), influenza (FLU), parainfluenza (PIV), human metapneumovirus (hMPV), and adenovirus (AdV) ( Table 9 .1). Antiviral resistance is of considerable concern among immunocompromised patients infected with influenza virus, and testing should be strongly considered in SOT undergoing treatment who fails to have an appropriate clinical response within 3-5 days of initiating antiviral therapy or who has a relapsing course despite ongoing therapy. Adjunctive therapy with corticosteroids has been purposed for SOT with influenza and RSV and for lung transplant recipients with any RVs with LRTI because of the risk of both acute and chronic rejection [13] . Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients	./cache/cord-018884-os0faovj.txt	./txt/cord-018884-os0faovj.txt